Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone
Halaw, M., Abu Shady, M., Eid, Y., EL Sherbeney, A., Mohamed, W. (2015). Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone. EKB Journal Management System, 1(1), -. doi: 10.4103/2356-8062.159994
M R. Halaw; M M. Abu Shady; Y M. Eid; A. A. EL Sherbeney; W. W. Mohamed. "Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone". EKB Journal Management System, 1, 1, 2015, -. doi: 10.4103/2356-8062.159994
Halaw, M., Abu Shady, M., Eid, Y., EL Sherbeney, A., Mohamed, W. (2015). 'Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone', EKB Journal Management System, 1(1), pp. -. doi: 10.4103/2356-8062.159994
Halaw, M., Abu Shady, M., Eid, Y., EL Sherbeney, A., Mohamed, W. Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone. EKB Journal Management System, 2015; 1(1): -. doi: 10.4103/2356-8062.159994

Study of vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone

​​Egyptian Journal of Obesity, Diabetes and Endocrinology
Volume 1, Issue 1, January 2015  XML PDF (881.77 K)
DOI: 10.4103/2356-8062.159994
View on SCiNiTO View on SCiNiTO
Authors
M R. Halaw; M M. Abu Shady; Y M. Eid; A. A. EL Sherbeney; W. W. Mohamed
Abstract
Objective
The aim of this study was to evaluate vitamin D level in type 2 diabetic patients before and after treatment with pioglitazone and assess any possible relationship with type 2 diabetic patients who are pioglitazone naive.
Participants and Methods
The study included 50 female participants; of them, 20 were healthy female participants who served as controls and 30 were pioglitazone-naive diabetic patients. All individuals were subjected to history taking and clinical examination, including fasting blood sugar, 2 h postprandial, glycosylated hemoglobin (HbA1c), lipid profile test (total cholesterol, HDL, LDL, triglycerides), kidney function tests (serum creatinine and calculated glomerular filtration rate), and evaluation of serum calcium, phosphorus, and alkaline phosphatase and serum 25-hydroxy vitamin D (by enzyme linked immunosorbant assay) before (basal) and after 3 months of treatment with pioglitazone.
Results
There was an nonsignificant elevation of vitamin D in group 2b (diabetic patients after using pioglitazone for 3 months), in comparison with vitamin D level in group 2a (diabetic patients before using pioglitazone) ( = 0.117). Vitamin D levels were found to be inversely associated with HbA1c levels in type 2 diabetic patients ( = 0.000 linear regression analysis); it was also found to be inversely associated with fasting and 2 h postprandial blood sugar levels ( < 0.000).
Conclusion
Vitamin D could impact glycemic control in terms of the inverse relation of vitamin D with HbA1c%, and at the same time poor glycemic control could impact vitamin D status in uncontrolled diabetic patients. Thiazolidinediones do not have significant effect on vitamin D level in female diabetic patients.
Keywords
Diabetes mellitus; Pioglitazone; Vitamin D
Statistics
Article View: 8
PDF Download: 4